Search clinical trials for: 21-144

Total 6283 results

Memorial Sloan Kettering Cancer Center
Janssen Scientific Affairs, LLC

Active, not recruiting

A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

Metastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Iovance Biotherapeutics, Inc.

Active, not recruiting

A Study of LN-144 in People With Metastatic Melanoma to the Brain

Metastatic Melanoma

United States
Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population

Healthy Volunteer | Vasomotor System; Labile

China
Changchun GeneScience Pharmaceutical Co., Ltd.
Syneos Health

Recruiting

A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers

Vasomotor Symptoms | Adult Healthy Volunteers

Australia
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Active, not recruiting

The Physiological Effects of FGF21 on Alcohol Preference and Glucose Metabolism (AlcoPref)

Fibroblast Growth Factor 21 | Tast Perference

Denmark
Provitro GmbH
Charite University, Berlin, Germany; AstraZeneca

Completed

Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

Mutations in Exons 18 to 21

Germany
IlDong Pharmaceutical Co Ltd

Unknown

Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers

Healthy
Memorial Sloan Kettering Cancer Center
Iovance Biotherapeutics, Inc.

Recruiting

Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma

Melanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal Melanoma

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Effects of "in UTERO" Exposure to Glucocorticoids (GLUCODEX)

21-hydroxylase; Defect

France
Hacettepe University

Completed

Serum Fibroblast Growth Factor-21 Levels During Prolonged Fasting

Fasting | Fibroblast Growth Factor-21

Turkey
InLight Solutions
TruTouch Technologies

Completed

Noninvasive Blood Ethanol Measurement With Infrared Spectroscopy

Healthy Individuals | At Least 21 Years of Age

United States
Avilex Pharma

Completed

A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144

Tolerance | Safety Issues

Finland
Nutrition 21, Inc.

Completed

Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM

Diabetes Mellitus, Type 2
Maasstad Hospital

Recruiting

Refraining From Closed Reduction of Dislocated Distal Radius Fractures in the Emergency Department (RECORDED)

Wrist Injuries | Distal Radius Fractures | Radius Fracture Distal | Wrist Fractures | Closed Reduction of Fracture and Application of Plaster Cast

Netherlands
Assiut University

Not yet recruiting

Diagnostic Value of Bronchoscopic and Thoracoscopic Frozen Section Biopsies in Patients With Pleuropulmonary Tumors

Event of Undetermined Intent (Y21-Y33)
Tristan Buck
Emma Childrens Hospital Foundation; European Paediatric Orthopaedic Society...

Not yet recruiting

CAsting and REhabilitation Versus Supervised Neglect for Osteochondral Lesions of the Talus in the Pediatric Population (CARE)

Rehabilitation | Cartilage Injury | Orthopedic Disorder | Physiotherapy | Skeletal Injury

Netherlands
Henry Ford Health System
University of Michigan; Geisinger Clinic

Completed

Encouraging Young Adults to Make Effective Nutrition Choices (MENU GenY)

Improve Dietary Behaviors in Young Adults 21-30 Years of Age

United States
WaveForm Technologies Inc.

Completed

Glucomen Day Cascade CGM System 21-Day Wear Study (GLUCODAY21)

Efficacy of a 21-Day Wear Period for the Cascade CGM

Croatia, Slovenia
Nutrition 21, Inc.

Completed

A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM

Diabetes Mellitus, Type 2

United States
Iovance Biotherapeutics, Inc.

Active, not recruiting

Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma (LN-144)

Metastatic Melanoma

United States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
Eli Lilly and Company
CoLucid Pharmaceuticals

Completed

Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment

Migraine Disorders

Belgium, Germany, France, Spain, Finland
Nutrition 21, Inc.

Unknown

Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules (Probiomega)

Signs and Symptoms, Digestive

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Albert Einstein College of Medicine

Recruiting

Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

Lynch Syndrome

United States
VALISH study
Japan Cardiovascular Research Foundation

Completed

Valsartan in Elderly Isolated Systolic Hypertension Study (VALISH)

Aged | Systolic Hypertension

Japan
Nobelpharma

Completed

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Cytomegalovirus Disease

United States, Japan
Takeda

Completed

A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

Premenopausal Breast Cancer

Japan
Iovance Biotherapeutics, Inc.

No longer available

Expanded Access Program of Lifileucel (LN-144) in Patients With Unresectable or Metastatic Melanoma

Metastatic Melanoma | Unresectable Melanoma

United States
Novo Nordisk A/S

Terminated

Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer

Cancer | Malignant Melanoma

Germany
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Advanced Pancreatic Adenocarcinoma
NHS Greater Glasgow and Clyde
University of Glasgow; Chief Scientist Office of the Scottish Government

Recruiting

CISCO-21 Prevent and Treat Long COVID-19. (CISCO-21)

Covid19

United Kingdom
Alanya Alaaddin Keykubat University

Completed

Effectiveness of Telerehabilitation Exercise for Bening Paroxysmal Positional Vertigo

Benign Paroxysmal Vertigo

Turkey
Takeda

Completed

A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy

Prostate Cancer

Japan
Assistance Publique - Hôpitaux de Paris

Unknown

Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency. (EVAF-21)

Adrenal Hyperplasia, Congenital | 21-hydroxylase Deficiency

France
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Recruiting

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States
Verinata Health, Inc.

Completed

MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy (MELISSA)

Pregnant Women | Prenatal Care

United States
Memorial Sloan Kettering Cancer Center
Rockefeller University; Pin Down Bladder Cancer Research Foundation

Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Non-muscle Invasive Bladder Cancer

United States
Université de Montréal
Institut de Recherche Robert-Sauvé en Santé et en Sécurité du Travail

Unknown

Impact of Thermal Stress on Pulmonary Absorption and Toxicokinetics of 3 Organic Solvents

Heat

Canada
Veradermics, Inc.

Recruiting

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Warts | Common Wart | Verruca Vulgaris

United States
Seneque SA
CEN Biotech; LGD

Completed

Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults

Healthy Volunteers

France
Aelis Farma
European Commission

Recruiting

Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome (MDDS)

Down Syndrome

Spain
University of Colorado, Denver
National Institute on Aging (NIA)

Recruiting

Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome

Down Syndrome

United States
Asahi Kasei Medical Co., Ltd.

Completed

Clinical Study of Asahi ViE Dialyzer in Canada (AVID)

Kidney Failure, Chronic
Daniel Gaudet
Ultragenyx Pharmaceutical Inc

Active, not recruiting

Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia

Canada
Daewoong Pharmaceutical Co. LTD.

Completed

To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.

Covid19

Korea, Republic of
Laboratoire Boreaderme Inc.
Ecogene 21

Unknown

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Recurrent Herpes Labialis
Perha Pharmaceuticals
Fondation Jérôme Lejeune; European Innovation Council; France 2030 program

Recruiting

Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease (LEUCETTA)

Healthy Volunteers | Down Syndrome | Alzheimer's Disease

France
University Hospital, Strasbourg, France

Unknown

Trisomy 21 in Adulthood

Down Syndrome

France
Hvivo
Pfizer

Recruiting

Dose, Safety, and Pathogenicity of a New Influenza B Strain

Influenza B

United Kingdom
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Metastatic Solid Tumor | Advanced Cancer

United States
ISDIN
Digna Biotech S.L.

Completed

Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study

Skin Fibrosis

United Kingdom, Spain, Italy, Poland, Germany, Hungary

Search clinical trials for: 21-144

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations